Bromfenac(Duract)-Associated Hepatic Failure Requiring Liver Transplantation

Hunter, Ellen B.; Johnston, Philip E.; Tanner, Gordon; Pinson, C. Wright; Awad, Joseph A.
August 1999
American Journal of Gastroenterology;Aug1999, Vol. 94 Issue 8, p2299
Academic Journal
Bromfenac sodium (Duract) is a phenylacetic acid-derived nonsteroidal anti-inflammatory agent introduced in the United States in 1997 and withdrawn in 1998. We describe the first case of fulminant hepatic failure associated with this agent treated successfully with liver transplantation. Similarities to hepatotoxicity with related agents is discussed.


Related Articles

  • Fulminant hepatic failure in woman with iron and non-steroidal anti-inflammatory drug intoxication. Magdalan, Jan; Zawadzki, Marcin; Sozański, Tomasz // Human & Experimental Toxicology;Aug2011, Vol. 30 Issue 8, p1106 

    A 17-year-old, previously healthy female ingested 16,000 mg iron sulphate (96.15 mg of iron ions per kg of b.wt.) with a suicidal intent. The patient was admitted to a toxicology unit 10 hours after the drug ingestion. Serum iron concentration at admission was 2351 μg% (421.0 μmol/L). In...

  • Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen). Gulmez, Sinem; Larrey, Dominique; Pageaux, Georges-Philippe; Lignot, Severine; Lassalle, Régis; Jové, Jérémy; Gatta, Angelo; McCormick, P.; Metselaar, Harold; Monteiro, Estela; Thorburn, Douglas; Bernal, William; Zouboulis-Vafiadis, Irene; Vries, Corinne; Perez-Gutthann, Susana; Sturkenboom, Miriam; Bénichou, Jacques; Montastruc, Jean-Louis; Horsmans, Yves; Salvo, Francesco // Drug Safety;2013, Vol. 36 Issue 2, p135 

    Background: Most NSAIDs are thought to be able to cause hepatic injury and acute liver failure (ALF), but the event rates of those leading to transplantation (ALFT) remain uncertain. Objectives: The aim of the study was to estimate population event rates for NSAID-associated ALFT Methods: This...

  • Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). Gulmez, Sinem; Larrey, Dominique; Pageaux, Georges-Philippe; Lignot-Maleyran, Séverine; Vries, Corinne; Sturkenboom, Miriam; Perez-Gutthann, Susana; Bénichou, Jacques; Bissoli, Franco; Horsmans, Yves; Bernuau, Jacques; Stricker, Bruno; Thorburn, Douglas; Blin, Patrick; Moore, Nicholas // European Journal of Clinical Pharmacology;Mar2013, Vol. 69 Issue 3, p605 

    Purpose: The European Committee for Human Medicinal Products (CHMP) requested a multinational study with the aim to investigate the risk of acute liver failure (ALF) leading to registration for transplantation in patients exposed to non-steroidal anti-inflammatory drugs (NSAIDs). The method of...

  • Post-Authorisation Safety Studies (PASS).  // Drug Safety;2011, Vol. 34 Issue 10, p895 

    An abstract of the "NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Principal Results of the 7-County Case-Population Study (SALT)," by D. Larry and colleagues is presented.

  • Melting point and softening time of suppositories containing nonsteroidal anti-inflammatory drugs. Orlova, T.; Pankrusheva, T. // Pharmaceutical Chemistry Journal;Jul2010, Vol. 44 Issue 7, p401 

    The melting point of lipophilic base mixtures for suppositories comprising confectionary fats with various surfactants including emulsifying cetostearyl alcohol type B (1 - 10%), emulsifier T-2 (1 - 5%), sodium lauryl sulfate (0.2 - 5%), and phospholipid concentrate (0.1 - 1%) has been...

  • Ulcerogenita kortikoidu - pre��vaj�c� m�tus mezi cesk�mi l�kari. Hlavov�, K.; Mart�nek, J.; Z�vada, F.; Zavoral, M.; Urban, O.; Rejchrt, S. // General Practitioner / Prakticky Lekar;Dec2011, Vol. 91 Issue 12, p710 

    Corticosteroids were once considered highly ulcerogenic drugs. Despite the fact that many studies have not confirmed this fact, a large percentage of doctors still consider them as ulcerogenic. Even the renowned textbooks from various disciplines do not consider corticosteroids ulcerogenic...

  • Comparison of the Tolerability of Diclofenac and Nepafenac. Achiron, Asaf; Karmona, Lily; Mimouni, Michael; Gershoni, Assaf; Dzhanov, Yana; Gur, Zvi; Burgansky, Zvia // Journal of Ocular Pharmacology & Therapeutics;Nov2016, Vol. 32 Issue 9, p601 

    Purpose: Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the prevention and treatment of inflammation and pain following cataract surgery. Preservative-free diclofenac and nepafenac drops are commonly used ophthalmic NSAIDs. The purpose of this study was to...

  • Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Boelsterli, U.A.; Boelsterli, Urs A // Drug Safety;Jul2002, Vol. 25 Issue 9, p633 

    Nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with idiosyncratic hepatotoxicity in susceptible patients. The molecular mechanisms underlying this toxicity have not yet been fully elucidated. However, experimental evidence suggests that they include increased concentration of...

  • Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury. Jinghai J. Xu; Peter V. Henstock; Margaret C. Dunn; Arthur R. Smith; Jeffrey R. Chabot; David de Graaf // Toxicological Sciences;Sep2008, Vol. 105 Issue 1, p97 

    Drug-induced liver injury (DILI) is the most common adverse event causing drug nonapprovals and drug withdrawals. Using drugs as test agents and measuring a panel of cellular phenotypes that are directly linked to key mechanisms of hepatotoxicity, we have developed an in vitro testing strategy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics